Great Lakes Advisors, LLC Catalent, Inc. Transaction History

Great Lakes Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $19.9 Million - $26.3 Million	-211,409 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$119.57 - $139.07 $10.2 Million - $11.9 Million	85,334 Added 67.69%	211,409 $27.1 Million
Q3 2021 Nov 09, 2021	BUY	$109.17 - $142.35 $13.8 Million - $17.9 Million	126,075 New	126,075 $16.8 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.